Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- TCMD +23%, UPWK +19%, SGHC +13.8%, KFRC +12.1%, INVX +10.8%, DAVE +10%, SANM +9.9%, PAY +9.8%, FWRG +9.8%, EXAS +9.2%, LTH +9%, HSIC +8.1%, CPRI +6.7%, GPN +6.5%, FN +6.1%, JBTM +5.9%, AUDC +5.9%, SXC +5.5%, EVER +5.3%, MDGL +5%, INSP +4.8%, AHCO +4.8%, AUPH +4.4%, YUMC +4%, GENI +3.9%, VVX +3.5%, CRVL +3.4%, HOG +3.4%, SLAB +3.4%, SPOT +3.3%, STRL +3%, PHG +2.9%, APO +2.9%, ACLS +2.7%, OFIX +2.7%, CLX +2.5%, PJT +2.5%, BRSL +2.3%, SHC +2.3%, YUM +2.2%, ORA +2.1%, FOLD +2.1%, CMRE +2.1%, BCC +1.9%, GT +1.7% (also completes divestiture of Goodyear Chemical business), IT +1.7%, VNO +1.6%, RACE +1.5%, MPLX +1.5%, COMP +1.5%, PCH +1.3%, IIPR +1%
Other news:
- DENN +49.6% (to be acquired by TriArtisan Capital Advisors; also reported earnings)
- PRLD +9.8% (announces an exclusive option agreement with Incyte (INCY) focused on Prelude's previously undisclosed mutant selective JAK2V617F JH2 inhibitor program in development for patients with myeloproliferative neoplasms)
- FULC +5.1% (to present data from PIONEER trial of Pociredir)
- PLX +2.5% (seeks re-examination for Elfabrio)
- YUM +2.2% (partners with Optimus Energy to bring EV stations to Saucy locations)
- MSBI +2.1% (authorizes new $25 mln share repurchase program)
- GVA +1.9% (awarded $70 mln contract by the Tucson Airport Authority)
- VALN +1.8% (reports Phase 1 results for second-generation Zika vaccine candidate)
- AIR +1.6% (acquires HAECO Americas from HAECO Group)
- SITC +1.5% (sale of Parker Pavilions for $8.4 mln)
- DXPE +1% (completes acquisition of Triangle Pump & Equipment)